Posts Tagged ‘counterfeit drugs’
Counterfeit Combat Chinese Partnership for Safe Medicines
政府和多边举措 药品打假是一场全球性的斗争，涉及许多政府组织和政府间组织。本页提供有关这些组织的指南。如果您要在本页中添加举措，请联系我们。 世界卫生组织 伪劣药品。情况说明书编号 275。2006 年 2 月更新。 伪劣药品一般信息。点此进入主页。 药品打假措施的制定方针。文档 WHO/EDM/QSM/99.1，点此在线浏览。 国际药品打假工作组 (IMPACT) IMPACT 代表国际药品打假工作组 (International Medical Products Anti-Counterfeiting Taskforce)。它是由世界卫生组织及其合作伙伴推出的举措，其中包括 Partnership for Safe Medicines。本页包含的信息涉及 IMPACT 宣传交流团队的多项工作： 活动日程、成功培训材料范例以及多媒体档案。您可以向 information@safemedicines.org 提交具有展示价值的材料。 其他多边举措 OECD： 经济合作与发展组织 OECD/WIPO 就如何衡量伪造及盗版情况召开的会议。2005 年 10 月 17-18 日 美国 食品与药品管理局 FDA 药品打假主页 2006 年 6 月工作组报告。 2006 年 2 月关于 FDA 药品打假举措的公开讨论会和供应商展出 2005…
[...]Protecting Yourself & Your Family Partnership for Safe Medicines
Protecting Yourself & Your Family Patients and providers need to be on alert and aware of the real risks associated with online pharmacies and counterfeit medicines. Learn about counterfeit medicines in order to avoid, detect, and report them. You can minimize your risk of getting a counterfeit medicine, and you can also fight back by reporting these cases to the…
[...]Counterfeit Drugs: Stay Informed Partnership for Safe Medicines
Counterfeit Drugs Whether you live in the United States, Russia, or Ghana, counterfeit drugs are a serious patient safety problem all around the globe. Not only do counterfeit drugs defraud consumers, they deny ill patients the therapies that can alleviate suffering and save lives. And in some cases, counterfeit drugs cause great harm and fatalities.…
[...]Liang BA.* Pigs, Drugs, and Terrorists. Patient Safe Qual Healthcare. 2008 Nov 1:10-12
Abstract. Making drugs is messy. Take heparin.You raise pigs and then slaughter them. You isolate the pig intestines and cook them. Then you scrape the intestinal insides, dry them, and get them to a factory to undergo more processing (Harris, 2008). Making drugs is also expensive. Outsourcing this messy activity to countries such as China…
[...]Shepherd MD.* Impact of Drug Importation on Community Pharmacy and Patient Care. J Am Pharm Assoc. 2007 May-Jun ;47:319-20, 323-4, 327
Abstract. With the political powers shifting in both congressional houses, many pharmaceutical issues have resurfaced in the 110th Congress. One of these is legalization of drug importation. Many Democrats and Republicans have already stated that this is a high-priority item. In the first 60 days of the First Session, two bills were introduced that would…
[...]